Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-19-060087

Options or other derivatives

  • Director acquired 100,987.62 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Harsh Michael · Director

Table II: Derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-11 Grant or award : show line 1 in the form Stock option (right to buy) +89,922 89,922 D
2019-12-11 Grant or award : show line 2 in the form Series A Convertible Preferred Stock +9.62 $1,143.68 $11,000 9.62 D
2019-12-11 Grant or award : show line 3 in the form Warrants +11,056 11,056 D
Loading xslF345X03/doc4.xml…